Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Elicio Therapeutics (ELTX)

Annual Return

Over the past 3 years, ELTX has had an average annual return of -32.69%, underperforming the benchmark SPY, which returned +19.31% annual.

Over the past 5 years, ELTX has had an average annual return of -51.27%, underperforming the benchmark SPY, which returned +12.55% annual.

Since Feb 5, 2021, ELTX has had an average annual return of -52.17%, underperforming the benchmark SPY, which returned +14.19% annual.

202620252024202320222021
-61.75%+56%-38.78%+2.73%-72.01%-82.96%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-4.49%+70.69%-17.69%-0.64%+7.69%-65.77%-22.17%-61.75%
2025+82.33%-10.79%-25.82%-20.17%+47.06%+6.82%+26.87%+7.47%+3.88%-15.09%+0.73%-14.91%+56%
2024-47.14%-7.72%+87.03%+21.03%-14.23%-48.06%+26.14%-26.64%+32.74%-15.54%+19.60%+0.33%-38.78%
2023-11.32%-11.11%-9.31%+30.79%+29.15%-3.12%+0.54%-13.55%+2.27%-20.36%-8.61%+35.73%+2.73%
2022-6.92%-31.08%+14%-41.09%+40.87%-35.20%-5.22%-5.67%-9.68%+8.69%-15.31%-4.22%-72.01%
2021+1.88%+4.21%-21.80%+9.27%-15.67%-18.35%+3.57%-11.27%-57.32%-13.67%-19.43%-82.96%

Drawdown analysis of Elicio Therapeutics (ELTX)

The maximum drawdown for the ELTX was -98.93%, occurring on Jun 16, 2026. This drawdown has not yet recovered.

The current ELTX drawdown is -98.82%.

Since Feb 5, 2021 ELTX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-98.93%Feb 22, 20211335Jun 16, 2026OngoingOngoingOngoing
-1.48%Feb 8, 20211Feb 9, 20212Feb 11, 20213